In the absence of telomerase, tumours may exploit a telomerase-independent mechanism for the telomere elongation known as ALT (Alternative Length Telomerase) phenotype, which is associated with inactivating mutations in ATRX or DAXX genes. This evidence concerns the gene ATRX and neoplasm.